MorphoSys AG
TREATMENT FOR RHEUMATOID ARTHRITIS
Last updated:
Abstract:
The present invention provides anti-GM-CSF antibodies for use in the treatment of rheumatoid arthritis. Anti-GM-CSF antibodies, in particular MOR103, are administered to patients suffering from rheumatoid arthritis at dosages that are beneficial in a clinical setting.
Status:
Application
Type:
Utility
Filling date:
8 Jan 2021
Issue date:
6 May 2021